DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
DarioHealth Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.49−0.33 (-6.85%)
Close on Oct 19, 2026
- Market cap
- $41.95M
- P/E (TTM)
- 1.1
- Dividend yield
- –
DarioHealth Corp. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumer hardware | $2.59M | $2.76M | $2.05M | $1.80M | $1.71M | $1.88M | $1.83M | $1.82M | $1.60M | $1.60M | $1.70M | $1.75M | 50.1% | +51.8% |
| Services | $2.59M | $2.83M | $3.18M | $3.21M | $3.66M | $4.88M | $5.77M | $5.60M | $4.66M | $4.16M | $1.91M | $1.77M | 49.9% | -29.4% |
| Agreement with National Health Plan | – | – | – | – | – | – | – | – | – | – | $0 | $0 | – | – |
| Development Services Per Exclusive Agreement Year Two [Member] | – | – | – | – | – | – | – | – | – | – | $0 | $0 | – | – |
| Development Services Per Exclusive Agreement Year Three [Member] | – | – | – | – | – | – | – | – | – | $489.00K | $582.00K | $200.00K | – | – |
| SaaS services | – | – | – | – | – | $1.29M | – | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of DarioHealth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.